Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2728 results

Sort By:

Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)

Study ID: NCT07033689
Start Date: 2025-12-01
End Date: 2027-03-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

10

Intervention / Treatment

Suizenji (an ultrasound-guided HIFU therapy system)

Nal-IRI/FL

mFOLFIRINOX adjuvant chemotherapy

Gem/nab-PTX

Sponsor

SONIRE Therapeutics Inc.

Source: clinicaltrials.gov

Share:
Add to list

Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel)

Study ID: NCT07200089
Start Date: 2026-01-31
End Date: 2028-07-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

40

Intervention / Treatment

NT-I7

Placebo

B-cell Maturation Antigen (BCMA) CART-T therapy

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma

Study ID: NCT06815432
Start Date: 2025-12-03
End Date: 2044-12-03
Study Type

Interventional

Study Phase

Phase1

No. of Participants

27

Intervention / Treatment

15.GPC3-CAR T cells

Sponsor

Baylor College of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Novel Treatment of Radiation Associated Dysphagia With Statins

Study ID: NCT07217938
Start Date: 2025-12-01
End Date: 2028-10-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

48

Intervention / Treatment

Pravastatin 40 Mg Oral Tablet

Sponsor

Peter MacCallum Cancer Centre, Australia

Source: clinicaltrials.gov

Share:
Add to list

BPL-1357 Against H1N1 Influenza Virus Challenge

Study ID: NCT07215858
Start Date: 2026-03-02
End Date: 2028-03-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

126

Intervention / Treatment

BPL-1357 IM

BPL-1357 IN

Placebo IM

Placebo IN

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy

Study ID: NCT07220785
Start Date: 2026-01-30
End Date: 2028-09-08
Study Type

Interventional

Study Phase

Phase3

No. of Participants

28

Intervention / Treatment

mibavdemab

Placebo

Sponsor

Regeneron Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Multicenter Pediatric Low-Dose CT Protocol: Development and Clinical Verification

Study ID: NCT07199101
Start Date: 2026-01-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

2650

Intervention / Treatment

Low dose CT

Sponsor

Beijing Children's Hospital

Source: clinicaltrials.gov

Share:
Add to list

The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa

Study ID: NCT02018692
Start Date: 2026-03-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Dunaliella algae Bardawil powder

Placebo:Starch

Sponsor

Sheba Medical Center

Source: clinicaltrials.gov

Share:
Add to list

The Role of Estrogen and Testosterone in Determining Heart, Lung, and Brain Regulation in Humans

Study ID: NCT07212712
Start Date: 2026-03-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

GnRH antagonist

Estradiol (E2)

Testosterone

Anastrozole (Arimidex)

Sponsor

University of British Columbia

Source: clinicaltrials.gov

Share:
Add to list

R01_Pilot Jaw Muscle Phenotypes

Study ID: NCT07153107
Start Date: 2025-11-10
End Date: 2026-01-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Local Heat Therapy

Sponsor

University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list